{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:02:06Z","timestamp":1769079726379,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,23]]},"DOI":"10.7759\/cureus.79521","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:27:26Z","timestamp":1740349646000},"source":"Crossref","is-referenced-by-count":1,"title":["Predictive Role of Lymph Node Germinal Centers in Postoperative Recurrence of Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Therapy"],"prefix":"10.7759","author":[{"given":"Yohei","family":"Kawaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehide","family":"Nakatsugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanako","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiyo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-021-00211-8","article-title":"Predictive biomarkers of anti-PD-1\/PD-L1 therapy in NSCLC","volume":"10","author":"Niu M","year":"2021","unstructured":"Niu M, Yi M, Li N, Luo S, Wu K. Predictive biomarkers of anti-PD-1\/PD-L1 therapy in NSCLC. Exp Hematol Oncol. 2021, 10:10.1186\/s40164-021-00211-8","journal-title":"Exp Hematol Oncol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip E","year":"2021","unstructured":"Felip E, Altorki N, Zhou C, et al.. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet. 2021, 398:1344-57.","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde PM","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, et al.. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022, 386:1973-85. 10.1056\/NEJMoa2202170","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee H","year":"2023","unstructured":"Wakelee H, Liberman M, Kato T, et al.. Perioperative pembrolizumab for early-stage non-small-cell lung cancer. N Engl J Med. 2023, 389:491-503. 10.1056\/NEJMoa2302983","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020231","article-title":"Tumor microenvironment features as predictive biomarkers of response to immune checkpoint inhibitors (ICI) in metastatic clear cell renal cell carcinoma (mccRCC)","volume":"13","author":"Simonaggio A","year":"2021","unstructured":"Simonaggio A, Epaillard N, Pobel C, Moreira M, Oudard S, Vano YA. Tumor microenvironment features as predictive biomarkers of response to immune checkpoint inhibitors (ICI) in metastatic clear cell renal cell carcinoma (mccRCC). Cancers (Basel). 2021, 13:10.3390\/cancers13020231","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman C","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019, 19:307-25. 10.1038\/s41568-019-0144-6","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher TN","year":"2022","unstructured":"Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science. 2022, 375:10.1126\/science.abf9419","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir A","year":"2022","unstructured":"Asrir A, Tardiveau C, Coudert J, et al.. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell. 2022, 40:318-34.e9. 10.1016\/j.ccell.2022.01.002","journal-title":"Cancer Cell"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva NS","year":"2015","unstructured":"De Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol. 2015, 15:137-48. 10.1038\/nri3804","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005531","article-title":"Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer","volume":"10","author":"Sun X","year":"2022","unstructured":"Sun X, Liu W, Sun L, et al.. Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer. J Immunother Cancer. 2022, 10:10.1136\/jitc-2022-005531","journal-title":"J Immunother Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005539","article-title":"Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer","volume":"11","author":"He M","year":"2023","unstructured":"He M, He Q, Cai X, et al.. Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer. J Immunother Cancer. 2023, 11:10.1136\/jitc-2022-005539","journal-title":"J Immunother Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.08.008","article-title":"Tumor-draining lymph nodes demonstrate a suppressive immunophenotype in patients with non-small cell lung cancer assessed by endobronchial ultrasound-guided transbronchial needle aspiration: a pilot study","volume":"137","author":"Murthy V","year":"2019","unstructured":"Murthy V, Katzman DP, Tsay JJ, et al.. Tumor-draining lymph nodes demonstrate a suppressive immunophenotype in patients with non-small cell lung cancer assessed by endobronchial ultrasound-guided transbronchial needle aspiration: a pilot study. Lung Cancer. 2019, 137:94-9. 10.1016\/j.lungcan.2019.08.008","journal-title":"Lung Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31941-w","article-title":"Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC","volume":"13","author":"Saddawi-Konefka R","year":"2022","unstructured":"Saddawi-Konefka R, O'Farrell A, Faraji F, et al.. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat Commun. 2022, 13:10.1038\/s41467-022-31941-w","journal-title":"Nat Commun"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw P","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, et al.. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016, 11:39-51. 10.1016\/j.jtho.2015.09.009","journal-title":"J Thorac Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyac034","article-title":"Overview of the ethical guidelines for medical and biological research involving human subjects in Japan","volume":"52","author":"Eba J","year":"2022","unstructured":"Eba J, Nakamura K. Overview of the ethical guidelines for medical and biological research involving human subjects in Japan. Jpn J Clin Oncol. 2022, 52:539-44. 10.1093\/jjco\/hyac034","journal-title":"Jpn J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1959978","article-title":"Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer","volume":"10","author":"Firmino NS","year":"2021","unstructured":"Firmino NS, Cederberg RA, Lee CM, et al.. Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer. Oncoimmunology. 2021, 10:10.1080\/2162402X.2021.1959978","journal-title":"Oncoimmunology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1 - update and clarification: from the RECIST committee","volume":"62","author":"Schwartz LH","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, et al.. RECIST 1.1 - update and clarification: from the RECIST committee. Eur J Cancer. 2016, 62:132-7. 10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636057","article-title":"A multi-omics analysis of metastatic melanoma identifies a germinal center-like tumor microenvironment in HLA-DR-positive tumor areas","volume":"11","author":"Gadeyne LH","year":"2021","unstructured":"Gadeyne LH, Van Herck Y, Milli G, et al.. A multi-omics analysis of metastatic melanoma identifies a germinal center-like tumor microenvironment in HLA-DR-positive tumor areas. Front Oncol. 2021, 11:10.3389\/fonc.2021.636057","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03093-1","article-title":"Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer","volume":"71","author":"Qin M","year":"2022","unstructured":"Qin M, Hamanishi J, Ukita M, et al.. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer. Cancer Immunol Immunother. 2022, 71:1431-42. 10.1007\/s00262-021-03093-1","journal-title":"Cancer Immunol Immunother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00292-y","article-title":"Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication","volume":"7","author":"Liu F","year":"2021","unstructured":"Liu F, Hardiman T, Wu K, et al.. Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication. NPJ Breast Cancer. 2021, 7:10.1038\/s41523-021-00292-y","journal-title":"NPJ Breast Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.04.016","article-title":"Prognostic impact of the number of metastatic lymph nodes on the eighth edition of the TNM classification of NSCLC","volume":"14","author":"Katsumata S","year":"2019","unstructured":"Katsumata S, Aokage K, Ishii G, et al.. Prognostic impact of the number of metastatic lymph nodes on the eighth edition of the TNM classification of NSCLC. J Thorac Oncol. 2019, 14:1408-18. 10.1016\/j.jtho.2019.04.016","journal-title":"J Thorac Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma","volume":"388","author":"Patel SP","year":"2023","unstructured":"Patel SP, Othus M, Chen Y, et al.. Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med. 2023, 388:813-23. 10.1056\/NEJMoa2211437","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000774","article-title":"Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study","volume":"110","author":"Deng H","year":"2024","unstructured":"Deng H, Zhou J, Chen H, et al.. Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study. Int J Surg. 2024, 110:238-52. 10.1097\/JS9.0000000000000774","journal-title":"Int J Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325898-predictive-role-of-lymph-node-germinal-centers-in-postoperative-recurrence-of-non-small-cell-lung-cancer-treated-with-immune-checkpoint-inhibitor-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:27:29Z","timestamp":1740349649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325898-predictive-role-of-lymph-node-germinal-centers-in-postoperative-recurrence-of-non-small-cell-lung-cancer-treated-with-immune-checkpoint-inhibitor-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.79521","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,23]]}}}